Butterfly Network Prepares for Third Quarter Financial Disclosure
Butterfly Network, Inc. (NYSE: BFLY), a pioneer in digital health technology, is set to announce its financial outcomes for the third quarter of 2024 on November 1, 2024, at 8:00 am ET. Headquartered in Burlington and New York, Butterfly Network has been redefining the landscape of medical imaging through its innovative portable, semiconductor-based ultrasound technology.
Conference Call and Webcast Details
Joseph DeVivo, who holds the roles of President, Chief Executive Officer, and Chairman of the Board, along with Heather Getz, the Executive Vice President and Chief Financial and Operations Officer, will lead a conference call and webcast to analyze the financial performance and operational developments of this quarter.
How to Join the Broadcast
The conference call will be available in a listen-only format via a webcast hosted on Butterfly’s Investor Relations website.
Dial-in Information
For those opting for a telephone connection, attendees can join the call by dialing in approximately ten minutes before the start time. The dial-in numbers are as follows:
U.S. domestic callers: +1 833-470-1428
International callers (Toll): +1 404-975-4839
Access Code: 668983
Availability of Replays
Following the live event, a replay of the conference call will be accessible on Butterfly’s Investor Relations page. For those interested in listening via phone, a telephone replay will be available until November 15, 2024, through the following numbers:
U.S. (Toll-Free): +1 866-813-9403
U.S. / International (Tolled): +1 929-458-6194
Access Code: 736364
About Butterfly Network and Its Innovations
Butterfly Network was established by Dr. Jonathan Rothberg in 2011. The company’s mission is to democratize access to medical imaging globally, ensuring that high-quality ultrasound technology is affordable and user-friendly. With an innovative handheld single-probe ultrasound device, the Butterfly iQ, the company has made significant strides in transforming ultrasound imaging. This technology is particularly crucial for the estimated 4.7 billion individuals worldwide who do not currently have access to ultrasound.
Advancements and Recognitions
Continuing its innovative journey, Butterfly launched its second-generation ultrasound system, Butterfly iQ+, in 2020, followed by the third-generation iQ3 in 2024, both featuring enhanced processing power and performance. Butterfly's groundbreaking technologies have gained accolades in various spheres, including recognition from TIME’s Best Inventions and CNBC’s Disruptor 50.
Global Reach and Availability
Today, Butterfly’s devices are used by trained healthcare practitioners in diverse regions, including parts of Africa, Asia, Australia, Europe, the Middle East, North America, and South America. To explore where Butterfly devices are available, interested individuals can check their official website.
Frequently Asked Questions
What is the purpose of the upcoming financial report?
The report aims to disclose Butterfly Network's financial performance and operational progress in Q3 2024.
Who will be presenting during the conference call?
Joseph DeVivo and Heather Getz will lead the presentation and discussion during the call.
How can I access the conference call?
The call can be accessed via a webcast on Butterfly’s Investor Relations webpage or through the provided dial-in numbers.
Will the call be available for replay?
Yes, after the live event, both the webcast and telephone replay will be accessible for a certain period.
What is Butterfly Network's mission?
Butterfly Network aims to make medical imaging accessible and affordable globally, primarily through ultrasound technology.
